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0939-4753/ª 2014 Elsevier B.V. All rights reseAbstract The pathogenesis of atherosclerosis, an age-related disorder, may be due to a prema-
ture biological ageing. Cellular senescence, the ﬁnite replicative lifespan of cells, plays a critical
role in the pathogenesis of atherosclerosis. The biological mechanism that triggers the onset of
cellular senescence is thought to be telomere shortening. The two major mechanisms respon-
sible for telomere shortening are the end-replication problem, oxidative DNA damage as well
as inﬂammation induced by environmental risk factors. Repair of the endothelium depends on
the presence of endothelial progenitor cells which depends on the hematopoietic stem cells
(HSC) reserves. In numerous past studies, short LTL has been associated with atherosclerosis.
Here we review the literature on telomere biology and coronary artery disease (CAD).
ª 2014 Elsevier B.V. All rights reserved.Introduction
Atherosclerosis, an age-related disorder [1] may recognize
as a determinant factor a premature biological ageing. In
fact cellular senescence, deﬁned as the ﬁnite replicative
lifespan of cells, plays a critical role in its pathogenesis
[2e4]. An important feature of atherosclerosis is vascular
endothelial cell dysfunction. Studies on atherosclerotic
plaques have demonstrated that endothelial and vascular
smooth muscle cells in atherosclerotic lesions display
changes of senescence [5,6]. In stable atheroscleroticem cells; CAD, coronary ar-
ere length,; MI, myocardial
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rved.plaques there are few senescent cells, whereas in
advanced, complicated plaques, senescent cells accumu-
late because of high cell turnover [7]. The biological
mechanism that triggers the onset of cellular senescence is
thought to be telomere shortening. Telomeres are struc-
tures composed of DNA repeats that protect the end of
chromosomes, but shorten at each cell division. Recently
their role in the onset, development and prognosis of
cardiovascular disease has generated considerable interest
leading to a number of studies investigating telomeres
length and cardiovascular disease. In this regard telomere
shortening has been reported to be associated also with
the classical risk factors for atherosclerosis such as insulin
resistance [8,9] diabetes [10e13], obesity [14], hyperten-
sion [8] and smoking [14,15].
Overall this would suggest that cellular senescence may
represent the ultimate event responsible for the patho-
logical changes characteristic of atherosclerosis. Such a
view would theoretically have several implications. Firstly
understanding the relation between telomere biology andres and atherosclerosis, Nutrition, Metabolism & Cardiovascular
2 L. Carulli, E. Annicchiaricocardiovascular disease may help elucidate ways to mea-
sure cardiovascular aging based not only on physiological
changes but also by the use of biomarkers such as leuko-
cyte telomere length (LTL). Secondly, it may help to better
deﬁne the need and the type of interventions on the risk
factors for atherosclerosis. Thirdly the understanding of
cardiovascular aging and telomere biology may help to
identify new strategies of interventions such as stem cell
therapy or agents that could retard this aging process
beyond conventional risk factors.
The telomere complex
Telomeres consist of repetitive DNA sequences (TTAGGG)
associated with a specialized protein complex named
shelterin and are located at the ends of linear chromo-
somes. They function as a cap to stabilize and protect
chromosomes from erosion and from being mistaken for
double-strand DNA breaks [16]. During each cell division,
telomeres shorten due to the “end-replication problem”
that is the DNA polymerase’s inability to fully replicate
the 30 end of chromosomes. In order to limit telomere
attrition, germline and some somatic cells express telo-
merase, a reverse transcriptase that maintains telomere
length by synthesizing new DNA sequences and adding
them to the end of the chromosome [17]. Telomerase is an
enzymatic protein complex including the telomerase
reverse transcriptase (TERT) and the telomerase RNA
component (TERC) used as a template to synthesize
telomere DNA. When telomeres are too short, they signal
the arrest of cell proliferation resulting in cell senescence
or apoptosis. If protective mechanisms, such as the p53
tumor-suppressor gene, are inactive, thus allowing
continued proliferation, telomeres become extremely
short and dysfunctional; they may cause chromosomes
end-to-end fusions and ultimately chromosomal insta-
bility. Conversely, cells transfected with the telomerase
gene can proliferate indeﬁnitely [18]. Despite telomerase
activity, telomere shortening is inevitable, thereby
limiting the proliferative lifespan of human cells. As ex-
pected, for a given organ, telomere length decreases with
the age of the subjects. There are also iatrogenic causes of
telomere shortening: for example after bone marrow
transplantation when hematopoietic stem cells and pro-
genitor cells are highly proliferative in order to recon-
stitute hematopoiesis. In addition, telomere attrition may
be genetically determined as a result of telomerase
complex’s genes mutations leading to an inherited
inability to elongate telomeres [19]. Variability in telo-
mere length is inﬂuenced by heredity, race and gender. It
is known that telomere length is shorter in healthy
offspring of patients with coronary artery disease (CAD)
[20,21]. This ﬁnding offers some explanation for the
increased familial risk of CAD and also implies that
shorter telomeres are likely a primary abnormality in the
pathogenesis of the disease [22]. It is also known African-
Americans have longer telomeres than Caucasians and
Indians [23e25] and females have longer telomeres than
their males counterparts [26].Please cite this article in press as: Carulli L, Annicchiarico E, Telome
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The atherosclerotic process is characterized by endothelial
cell dysfunction therefore is dependent on the balance
between injury and repair of the endotheliumeinjury from
oxidative stress and inﬂammation, and repair by hemato-
poietic stem cell reserves (HSC).
An important mechanism responsible for telomere
shortening is the oxidative DNA damage induced by
environmental risk factors (Fig. 1). Telomere shortening
induced by oxidative stress is proportional to telomere
length, as longer telomeres are larger targets for free
radicals [27,28]. Telomeres are exposed to reactive oxygen
species, which have a predilection for the single stranded,
G-rich telomere overhang. This site speciﬁcity for guanine
is because guanine is the most easily oxidized DNA base as
its oxidation potential is lower compared to the other
three bases. This is an important variable associated with
aging and with accelerating the telomere attrition [29]. An
important consequence of oxidative stress is the initiation
of an inﬂammatory response (Fig. 1). Chronic systemic
inﬂammation is responsible for an increase in peripheral
white blood cell turnover, which in turn leads to an
exaggerated telomere attrition rate [30]. The increased
white cell consumption induces hematopoietic stem cells
to divide, thereby shortening their telomere length as well.
Moreover exposure to TNF-a also reduces telomere length
by negative regulation of telomerase activity [31]. In
several studies it has been shown that short telomeres are
associated with the classical risk factor for atherosclerosis:
hypertension [8] diabetes [32,33], coronary artery disease,
carotid atherosclerosis [34,35] and stroke [14,36,37]. This
could be due to chronic inﬂammation that associates with
these clinical conditions and/or to the inﬂuence of a less
healthy life style, including smoking habit and alcohol
consumption [14].
Repair of the endothelium depends on the presence of
endothelial progenitor cells on the sites of vascular injury
to initiate repair. Endothelial progenitor cells are produced
by HSC, which, due to their higher telomerase activity,
have a greater proliferative capacity. Exhaustion of the
progenitor cell is an important factor in endothelial cell
dysfunction and shortened telomere length in HSC is
indicative of diminished reparative capacity [22,23].
Telomere length quantiﬁcation is generally determined
on DNA sourced from circulating white blood cells. The
problem is whether telomere length determination in
peripheral blood cells really reﬂects the tissue cell telo-
mere length. Some studies have shown that the correlation
between LTL and telomere length in vascular tissue really
exists. The study by Wilson et al. demonstrated that telo-
mere attrition in circulating blood leucocytes reﬂects
similar changes in the vasculature and is an acceptable
surrogate for vascular ageing in population studies [37]. In
concordance with this, there is evidence that the relation
between LTL and telomere length in various human tissues
is strong [38]. In another study LTL was related to the
presence of carotid atherosclerotic plaque but not with the
plaque telomere length; plaque telomere length wasres and atherosclerosis, Nutrition, Metabolism & Cardiovascular
Figure 1 Telomere shortening induced by inﬂammation and oxidative stress. Systemic inﬂammation through an increase in peripheral white blood
cell turnover and increased TNF-a also plasma levels, that reduces telomerase activity, leads to telomeres attrition as well as does oxidative stress
increasing HSC turnover.
Dietary patterns and lipoprotein subclasses 3related to the plaque characteristics and development of
restenosis after endarterectomy in a group of patients
undergoing angiography and intervention [39].Telomeres and classical atherosclerosis risk factors
It has been recently stressed the association of short
telomeres with the classical risk factor for atherosclerosis
(Fig. 2).Insulin resistance and diabetes
The pro-atherogenic mechanism of insulin resistance in-
cludes its systemic effects leading to dyslipidaemia, hy-
pertension and a pro-inﬂammatory state as well as direct
effects on vascular endothelial cells, smooth muscle cells
and macrophages [40].
In early atherosclerosis, insulin resistance causes
decreased nitric oxide production and an increase inPlease cite this article in press as: Carulli L, Annicchiarico E, Telome
Diseases (2014), http://dx.doi.org/10.1016/j.numecd.2014.07.004VCAM-1, which are responsible for impaired vasodilation
and inﬂammation.
In advanced plaques, insulin resistance triggers
apoptosis of cells via the Akt pathway [41e44].
Apoptosis of smooth muscle cells causing ﬁbrous cap
thinning and apoptosis of macrophages leading to plaque
necrosis are the pathological processes that precipitate
acute coronary syndromes.
In type 2 diabetes, hyperglycaemia “per se”, induces
oxidative stress [45e48] and ultimately leads to cellular
senescence. Cellular senescence and apoptosis occur not
only in vascular endothelial and smooth muscle cells but in
multiple cell lines, including endothelial progenitor
[49,50].
Therefore type 2 diabetes can be considered a
premature-ageing syndrome and several clinical studies
have shown an association between shorter telomere
length and type 2 diabetes (T2D) [10e13]. The extent of
telomere shortening seems to be gradual and reﬂecting
the severity of the disease and the presence of complica-
tions [51].res and atherosclerosis, Nutrition, Metabolism & Cardiovascular
Figure 2 Telomeres and classical atherosclerosis risk factors. The association between short telomeres and the classical risk factors for athero-
sclerosis might be mediated by systemic inﬂammation and oxidative stress and/or the inﬂuence of a less healthy life style (smoking habit, alcohol
consumption, physical inactivity) that usually associates with these conditions.
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ence on telomere length, in a study by Satoh et al. it has
been shown that CAD patients with the metabolic syn-
drome had shorter telomeres than CAD patients without
the metabolic syndrome [52]. Moreover among diabetic
patients, those with atherosclerotic plaques have greater
shortening of telomere length compared to those without
plaques [53].
Finally diabetic patients with myocardial infarction
have shorter telomeres than diabetic subjects without
myocardial infarction [13,54].
Based on these observations, it has been postulated that
critically shortened telomeres, due to a combination of
inherited short telomeres, oxidative stress and inﬂamma-
tion induced telomere attrition, caused by the common
risk factors, lead to cellular ageing in vascular endothelial,
and may be a useful biomarker of tissue ageing and disease
progression.Obesity
Adipose tissue is not only a source of ROS and pro-
inﬂammatory cytokines but also secretes of bioactive
peptides named “adipokines” that impact on multiplePlease cite this article in press as: Carulli L, Annicchiarico E, Telome
Diseases (2014), http://dx.doi.org/10.1016/j.numecd.2014.07.004functions including insulin sensitivity, angiogenesis and
blood pressure, lipid metabolism and hemostasis, all of
which inﬂuence the function and structural integrity of the
cardiovascular system [55,56].
Indeed obesity promotes the clustering of risk factors
such as dyslipidaemia, hypertension, diabetes and the
metabolic syndrome and obese subjects experience
elevated morbidity and mortality from all forms of car-
diovascular disease [57,58].
It is interesting to point out that the relation between
weight gain (BMI) and telomere shortening rate is
accounted for by increased insulin resistance rather than
body weight per se.
In the Bogalusa Heart study it was observed that the
relative changes in telomere length were correlated with
the homeostasis model assessment of insulin resistance
and changes in the body mass index [9].
In a study conducted on 1122 healthy adult female
twins it was observed that the telomere length in obese
women were 240 base pairs shorter compared to the lean
sibling and the difference in telomere length accounted for
8.8 years of ageing.
The study also suggested that the mechanism by which
obesity affects telomere length is through increased leptin
levels rather than BMI per se [14,59].res and atherosclerosis, Nutrition, Metabolism & Cardiovascular
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Systolic blood pressure rises with age and might be
considered as a phenotype of biological ageing. In a study
conducted on 49 twin pairs from the Danish Twin Register,
it was observed a signiﬁcant inverse correlation between
pulse pressure and telomere length [60] and this correla-
tion was highly familial.
In a study on 163 treated hypertensive males, Benetos
et al. observed that telomere length was shorter in hy-
pertensive men with carotid plaques compared to hyper-
tensive men without plaque. The ﬁndings from this study
suggest that in the presence of hypertension, which is a
major risk factor for carotid arteries atherosclerosis, short
telomere act as an important additional risk factor [61].
Smoking
Smoking appears to result in an elevation of biomarkers od
oxidant stress, some in a dose-related fashion. There is also
evidence that endothelial dysfunction in smokers may be
attributable to oxidative stress [62].
Several epidemiological studies, have shown an asso-
ciation between telomere shortening and smoking habit.
In the Flemish study on environment, genes and health
outcomes, shorter telomeres were observed in smokers
compared to non-smokers [26]. In another study women
who had never smoked had longer telomeres than former
smokers, and both had longer telomeres than current
smokers, moreover it was observed that the effect of
smoking habit on telomere length was dose-dependent;
each pack-year smoked was equivalent to the loss of an
additional ﬁve base pairs (18%) of telomere length
compared to the rate in the overall cohort [14].
The dose dependent effect was subsequently replicated
in another study conducted on a cohort of male smokers
with and without chronic obstructive pulmonary disease;
the study conﬁrmed that the smoking exposure enhances
telomere shortening and demonstrated a dose effect
relationship independently from the presence chronic
pulmonary obstruction [15].
Telomere length and atherosclerosis
It has been shown that in atherosclerotic regions of coro-
nary arteries, endothelial cells present characteristic fea-
tures of senescence and inhibiting telomere function
induced senescence, whereas introducing telomerase
suppressed senescence and extended the lifespan of
endothelial cells [3]. It is known that telomeres of coronary
endothelial cells are shorter in patients with CAD
compared to age-matched subjects without CAD and that
in the CAD patients, telomere length is shorter in endo-
thelial cells at atherosclerotic sites compared to non-
atherosclerotic sites [63]. Studies have also shown that
endothelial cells in regions of the vascular tree that are
subjected to greater hemodynamic stress have more pro-
nounced telomere attrition than endothelial cells from
areas with less stress [64], this is because that areas of thePlease cite this article in press as: Carulli L, Annicchiarico E, Telome
Diseases (2014), http://dx.doi.org/10.1016/j.numecd.2014.07.004vasculature that undergo greater shear wall stress have
higher cellular turnover rates and consequently shorter
telomere length [65]. This variable telomere attrition rate
indicates the signiﬁcant impact of environmental stress on
telomere length. In numerous past studies, short LTL has
been associated with CAD [23,34,66]. In the pioneering
study by Samani et al., it was observed that in patients
with early onset CAD with premature myocardial infarc-
tion (MI) had a shorter mean telomere length compared
with age and gender matched healthy subjects. Further-
more, although both groups experienced telomere attri-
tion with aging, there was a residual difference that served
as a marker of increased cardiovascular risk in those pa-
tients with early CAD [67]. In another study patients with
premature MI had signiﬁcantly shorter mean telomere
lengths compared to healthy subjects, with a consequent
calculated reduction in biological age of 11.3 years [68];
the same results were observed in a study that associated
shorter LTL with an increase in prospective risk of MI [69].
A study on 143 normal blood donors over the age of 60
years, showed that subjects with shorter telomeres had
poorer survival, with a 3.18-fold higher mortality rate from
heart disease [70]. In a sub-study of the West of Scotland
Primary Prevention Study (WOSCOPS) comparing telo-
mere lengths at recruitment in individuals who went on to
develop coronary heart disease events with those from
age-matched controls who remained free of CAD, it was
shown that subjects with shorter telomere length at the
time of recruitment had a signiﬁcantly higher risk of
developing subsequent coronary heart disease [71]. It has
been also observed that LTL is shorter in patients with
carotid plaques compared with those without, however,
further studies are needed to compare peripheral mea-
surements with those in central tissue to determine
whether there is a close correlation between measure-
ments as indicated previously [31]. Finally, in the pro-
spective population-based Bruneck study, baseline
telomere length was a signiﬁcant risk predictor for sub-
sequent myocardial infarction and stroke, independent of
standard risk factors. Of note in this study telomere length
was strongly associated with advanced pathology and
acute vascular syndromes but not early atherosclerosis [7].
Conclusion
Understanding the relation between telomere biology and
atherosclerosis may be important because of the high
incidence of both premature CAD in the general
population.
Short telomere in the early life may indicate a genetic
predisposition and therefore help identifying susceptible
individuals who may be appropriate targets for future
molecular therapies and candidates for educational and
surveillance programs.
In addition, in adult life telomere length might be a
measure of cumulative DNA damage from multiple envi-
ronmental risk factors, therefore it might be a better pre-
dictor of CAD than the currently available risk markers,
which are single, point measurements in time.res and atherosclerosis, Nutrition, Metabolism & Cardiovascular
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short telomere are needed to evaluate the real rate of as-
sociation of clinical or subclinical CAD and the prevalence
of telomeres shortening. Finally, novel therapies aimed at
delaying cellular senescence by manipulation of the telo-
mere/telomerase complex may be of beneﬁt.
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